Patents by Inventor Weina Zhang

Weina Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959178
    Abstract: A method is disclosed for treating an anodized metal surface. According to the method, polynuclear clusters comprising aluminum oxide hydroxide are applied to the anodized metal surface.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: April 16, 2024
    Assignee: HAMILTON SUNDSTRAND CORPORATION
    Inventors: Susanne M. Opalka, Weina Li, Joseph J. Sangiovanni, Mark R. Jaworowski, Georgios S. Zafiris, Weilong Zhang, Zhongfen Ding
  • Publication number: 20240117714
    Abstract: A method of increasing crude oil production by CO2 storage in an aquifer and dumpflooding includes the following steps. Wells are drilled in an aquifer in an oil-bearing basin for large-scale CO2 storage. A low-production and low-efficiency well in an oil-bearing stratum away from the CO2 storage injection well is selected as an artesian injection well. Formation water in the aquifer with increasing pressure is controlled and guided into the oil-bearing stratum to realize oil displacement by dumpflooding in the oil-bearing stratum.
    Type: Application
    Filed: December 21, 2023
    Publication date: April 11, 2024
    Inventors: Xianmin ZHANG, Qihong FENG, Chen LIU, Kuankuan WU, Zangyuan WU, Yiming ZHANG, Weina LIU, Jianwei GU
  • Publication number: 20200377551
    Abstract: Peptide constructs comprising a mitochondrial antiviral-signaling protein (MAVS) peptide and a cell penetration peptide are disclosed, which are useful for stimulating interferon production in vitro and in vivo. Lactate has been discovered to inhibit glycolysis-mediated retinoic acid-inducible gene I (RIG-I) like receptor signaling by directly binding to the MAVS transmembrane (TM) domain and preventing MAVS aggregation; peptide constructs according to the disclosure can prevent or reverse this inhibition to stimulate interferon production. Methods for stimulating interferon production in a cell are also described, as well as methods for the treatment of viral infections and cancer.
    Type: Application
    Filed: May 22, 2020
    Publication date: December 3, 2020
    Applicant: Wake Forest University Health Sciences
    Inventors: Hui-Kuan Lin, Weina Zhang, Guihua Wang
  • Publication number: 20120083489
    Abstract: The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and diabetes.
    Type: Application
    Filed: June 2, 2010
    Publication date: April 5, 2012
    Inventors: Siegfried Benjamin Christensen IV, Donghui Qin, Shenglin Chen, Xing Huang, Di Li, Fei Li, Lei Li, Xiaojuan Lin, Shi Lu, Zhen Lu, Maoyun Lv, Chuanning Wang, Chengde Wu, Mei Xiao, Haiyu Yu, Weina Zhang, Zhiliu Zhang
  • Publication number: 20120077794
    Abstract: The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and diabetes.
    Type: Application
    Filed: June 2, 2010
    Publication date: March 29, 2012
    Applicant: GLAXSMITHKLINE LLC
    Inventors: Siegfried Benjamin Christensen, IV, Donghui Qin, Shenglin Chen, Xing Huang, Di Li, Fei Li, Xiaojuan Lin, Shi Lu, Maoyun Lv, Chengde Wu, Weiliang Xu, Gang Yan, Jianxing Yuan, Weina Zhang, Zhiliu Zhang
  • Patent number: D914941
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: March 30, 2021
    Inventor: Weina Zhang